
Canopy Growth (CGC) Stock
Canadian cannabis producer for medical and adult markets. Here's the price, business snapshot, and what's worth knowing about Canopy Growth in September 2026.
Canopy Growth Corporation (CGC) is a Canadian cannabis producer active in adult‑use and medical markets, with branded products that include flower, oils, edibles and beverages. With a market capitalisation of US$645.37M, the company has shifted focus towards operational efficiency and portfolio rationalisation after several years of heavy investment and restructuring. Key considerations for investors are its exposure to regulatory change (particularly any US federal legalisation), competitive pressure from other licensed producers and consumer packaged goods companies, and ongoing challenges returning to sustained profitability. Liquidity, balance‑sheet strength and execution on cost savings are material variables to monitor. This summary is general educational information and not personal advice; cannabis stocks can be volatile and values may rise or fall. Investors should assess suitability relative to their objectives, risk tolerance and time horizon, and consider seeking regulated financial advice before acting.
About This Stock
CANOPY GROWTH CORPORATION
CGC
Current Price
$0.93
Potential 12 Month Profit
566.91%
Sector
Healthcare
Industry
Pharmaceuticals
Ticker
CGC
Market Cap
$541.49M
Potential 12 Month Profit
566.91%
Sector
Healthcare
Industry
Pharmaceuticals
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Canopy Growth Corporation's stock with a target price of $6.19, indicating potential growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Market recovery watch
Watch for signs of revenue stabilisation and margin improvement as indicators of recovery, though performance can vary and is not guaranteed.
Product innovation
New formats and branded products can drive consumer demand, but success depends on execution, distribution and changing consumer tastes.
Regulatory drivers
Shifts in regulation, especially in the US, could materially change the opportunity set, but regulatory outcomes are uncertain and carry risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.